Understanding how BAG3 protein affects neuron health and Alzheimer's disease

BAG3 regulates Rab35 and the ESCRT/endolysosome pathway

NIH-funded research University of Rochester · NIH-10864970

This study is looking at a protein called BAG3 to see how it helps keep brain cells healthy, especially in people with Alzheimer's disease, and it hopes to find new ways to protect these cells and improve treatment options.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Rochester NIH-funded
Lab location1 site (Rochester, United States)
Project IDNIH-10864970 on NIH RePORTER

What this research studies

This research investigates the role of the BAG3 protein in maintaining the health of neurons, particularly in the context of Alzheimer's disease. It focuses on how BAG3 regulates the endolysosome system, which is crucial for protein quality control in neurons. By studying the mechanisms through which BAG3 influences neuronal integrity and the accumulation of tau protein, the research aims to uncover potential therapeutic targets for Alzheimer's disease. Patients may benefit from insights that could lead to new treatments aimed at protecting neuronal health.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at risk for or diagnosed with Alzheimer's disease.

Not a fit: Patients with non-neurological conditions or those not affected by Alzheimer's disease may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by enhancing neuronal health.

How similar studies have performed: Previous research has shown promising results in understanding the role of protein quality control in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Rochester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.